ArticleIranian journal of microbiology2025
Serological epidemiology analysis of Cytomegalovirus infection in pregnant women in Diwaniyah, Iraq.
Article in Iranian journal of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: Human cytomegalovirus (HCMV) infection is the most common cause of congenital infection during pregnancy. It is a major concern worldwide with a wide range of clinical outcomes in fetuses and newborns due to HCMV reactivation or reinfection during pregnancy. Primary maternal infection is best diagnosed by examining IgM and IgG antibodies. The current study aimed epidemiology survey of congenital HCMV infection in pregnant women in Diwaniyah. Materials and Methods: 600 blood samples were collected from pregnant women, between 18-45 years old, in Diwaniyah Governorate for 12 months, from January to December 2022, in regards to their place of residence (urban or rural). All samples were monitored for both IgG and IgM antibodies against HCMV using rapid test and ELISA. Results: Our findings showed a high positive rate for IgG (95.7%) and (96.2%) and a positive rate for IgM (1.5%) and (1.8%) for rapid test and ELISA, respectively. The highest IgG positive rate was in the age group 26-35 years (43.33%), while the lowest rate (13.0%) was in the age group 36-45 years. The HCMV infection rate in rural and urban areas were (96.48%) and (95.26%), respectively, with no significant differences (P value>0.05). Also, the rate of miscarriages among pregnant women infected with HCMV was 28.83%, and the highest infection rate (30.51%) was recorded in the age group 26-35 years. Conclusion: The prevalence of HCMV infection and its related miscarriage among the studied population is relatively high with the highest rate in the age group of 26-35 years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.